Channel Therapeutics issues NYSE American-required announcement on going concern in 2024 10-K

Pelthos Therapeutics Inc.

2024 10-K audit opinion includes a going concern emphasis of matter (previously filed March 27, 2025).
Press release issued May 1, 2025 to comply with NYSE American Sections 401(h) and 610(b).
Announcement does not change or amend the audited financial statements or the 2024 10-K.
Company develops non-opioid pain therapeutics (no new business updates).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.